AFMD Total Utang marang Modal Affimed N.V.

Lambang korporat lan logo Affimed NV (AFMD)

Affimed revenues are based on the development of tumor therapies, where licensing royalties and partner payments for access to ROCK technology generate profit. Management is currently minimizing costs and optimizing research amid a shortage of funds. This price chart reflects a market trend for the asset with a debt-to-equity ratio of 0.00, while a staff of leading scientists continues to develop innovative cancer treatment methods.

AFMD: Total Utang marang Modal Affimed Therapeutics 04.07.2022 - 31.05.2025

Rincian analitis lan laporan data perusahaan Affimed N.V. (AFMD)

- rega lan prakiraan konsensus rega:
Bagan rega Affimed NV|AFMD - Bagan tingkat prakiraan
- data kapitalisasi pasar:
Kapitalisasi pasar Affimed|AFMD - Nilai Dipunlarasaken Utang lan Kas
- data kapitalisasi buku:
Nilai Buku saben Saham Affimed|AFMD - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku affimed.com|AFMD - Nilai Agregat Aset
- data utang lan likuiditas:
Utang marang Ekuitas Affimed|AFMD - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Affimed NV|AFMD - Gunggung utang perusahaan|Utang marang nilai buku Affimed
Analisis komprehensif perusahaan:AFMD - Affimed
Produk merek Affimed N.V.

This ratio measures the degree of financial leverage by comparing total borrowings against the net value of owner assets. Analyzing the total liabilities-to-equity ratio allows for an assessment of Affimed (AFMD) resilience to default, which is critical for the biotechnology sector, where the development of the ROCK platform and the receipt of royalties from partners require strict control over the debt load.

Pesaing utama

Utang marang Ekuitas argenx ARGX|Utang Agregat marang Ekuitas BioNTech Inc.|Abivax SA (ABVX) - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi ADMA Corp (ADMA)|Total Utang marang Modal PTGX (Protagonist Therapeutics)|immunovant.com - Total Utang marang Modal|Utang marang Ekuitas Kiniksa (KNSA)|GRFS: Rasio Kabeh Utang marang Dana Pribadi|ADPT (Adaptive Biotechnologies Corp) - Utang marang Ekuitas|Celldex Corp (CLDX) - Rasio Total Utang marang Ekuitas|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com (BCRX)|Vera Therapeutics (VERA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Dianthus Therapeutics Inc (DNTH)|Total Utang marang Modal PHVS|AbCellera - Koefisien Total Utang marang Modal|TRML: Utang marang Ekuitas|PGEN: Rasio Total Utang marang Ekuitas|PHAR (Pharming Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ZBIO|Utang marang Ekuitas Immunome, Inc. IMNM|Rasio Utang marang Ekuitas gossamerbio.com (GOSS)|KALV: Total Utang marang Modal|Utang marang Modal Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc - Total Utang marang Modal|SVRA - Total Utang marang Modal|Total Utang marang Modal Rigel Pharmaceuticals (RIGL)|anaptysbio.com (ANAB) - Utang Agregat marang Ekuitas|Total Utang marang Modal Astria Therapeutics, Inc. ATXS|Utang Agregat marang Ekuitas enGene Holdings Inc|RAPT (RAPT Therapeutics, Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal JBIO (aerovatetx.com)|Aclaris Therapeutics - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas kyvernatx.com KYTX|TLSA (Tiziana Life Sciences Ltd) - Total Utang marang Modal|CABA - Utang marang Modal|Total Utang marang Modal Ventyx Bio|Theratechnologies, Inc (THTX) - Rasio Utang marang Ekuitas|AVTX (Avalo Therapeutics, Inc) - Total Utang marang Modal|Total Utang marang Modal eledon.com|AGEN - Total Utang marang Modal|Utang Agregat marang Ekuitas CLYM (Climb Bio Inc.)|Zura Bio Limited - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas aTyr Pharmaceuticals ATYR|Adagene Corp (ADAG) - Total Utang marang Modal|IMA: Rasio Utang marang Ekuitas|Utang marang Ekuitas shattucklabs.com (STTK)|Equillium (EQ) - Utang Agregat marang Ekuitas|CNTB - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi Immunic Inc|Total Utang marang Modal ATRA|Total Utang marang Modal IFRX (inflarx.de)|Utang marang Ekuitas X4 Pharmaceuticals, Inc.|Adicet Bio Inc. - Rasio Kabeh Utang marang Dana Pribadi|CELU: Utang marang Ekuitas|INMB - Rasio Total Utang marang Ekuitas|BRNS: Total Utang marang Modal|Total Utang marang Modal kezarlifesciences.com|SABS - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Akari Therapeutics PLC|ENLV (Enlivex Therapeutics) - Total Utang marang Modal|Koefisien Total Utang marang Modal QTTB (q32bio.com)|GeoVax Labs, Inc. - Utang marang Ekuitas|edesabiotech.com - Rasio Total Utang marang Ekuitas|IBIO: Utang marang Ekuitas|Carisma Therapeutics (CARM) - Rasio Total Utang marang Ekuitas|XTLB: Rasio Total Utang marang Ekuitas|BOLT (Bolt Biotherapeutics, Inc.) - Total Utang marang Modal|Utang marang Ekuitas HCW Biologics, Inc. (HCWB)|Rasio Utang marang Ekuitas Aptevo|AIM ImmunoTech - Total Utang marang Modal|Utang marang Modal aditxt.com (ADTX)|Total Utang marang Modal GRI (GRI Bio Corp)|Total Utang marang Modal XORTX Corp XRTX|Total Utang marang Modal Vyome Holdings Inc|REVB - Utang Agregat marang Ekuitas|Total Utang marang Modal Indaptus Therapeutics, Inc. (INDP)|Scinai Immunotherapeutics Ltd (SCNI) - Utang Agregat marang Ekuitas|CALI: Total Utang marang Modal|Koefisien Total Utang marang Modal ALLK|Utang marang Ekuitas HOOK (HOOKIPA Pharma Inc.)|Rasio Total Utang marang Ekuitas igmbio.com (IGMS)|ITOS: Total Utang marang Modal|Utang marang Modal Ocean Biomedical Inc OCEA|TC BioPharm (Holdings) PLC (TCBP) - Total Utang marang Modal|THRD - Rasio Utang marang Ekuitas